The following Financial Services guidance note provides comprehensive and up to date legal information covering:
Following its work on shadow banking and investment funds, the European Commission identified a number of concerns about money market funds (MMFs). In response, the European Commission ('Commission') published the original proposal for a Regulation on Money Market Funds (MMF Regulation) in September 2013, following recommendations by the International Organization of Securities Commissions (IOSCO) and the Financial Stability Board (FSB). The MMF Regulation was published in the Official Journal of the EU on 30 June 2017, and applies to new MMFs from 21 July 2018 and to existing MMFs from 21 January 2019. The MMF Regulation is designed to increase investor protection and to limit the risk that money market funds (MMFs) pose to the integrity and stability of financial markets.
The MMF Regulation applies to MMFs established, managed or marketed in the EU, whether they are authorised as undertakings for the collective investment in transferable securities (UCITS) under UCITS IV and UCITS V (see Practice Notes: Key provisions of UCITS IV—authorisation of UCITS and UCITS V), or as alternative investment funds (AIF) under the Alternative Investment Fund Managers Directive (AIFMD). The MMF Regulation supplements the provisions of UCITS IV and the AIFMD and must be applied in addition to the rules laid down in both directives.
MMFs are an
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234